FDA panel endorses first antiviral treatment for COVID-19

Today, an expert panel of the Food and Drug Administration (FDA) endorsed the use of the Merck antiviral drug molnupiravir for treatment of symptomatic COVID-19 in test-confirmed patients with high risk conditions. The FDA has not yet authorized the treatment.